Drug target H1N2 (swine influenza) and H5N2 (avian influenza):ligand structure design

MAIN

©1996-2019 All Rights Reserved. Online Journal of Bioinformatics . You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJB publications. This article may be copied once but may not be, reproduced or re-transmitted without the express permission of the editors. This journal satisfies the refereeing requirements (DEST) for the Higher Education Research Data Collection (Australia). Linking:To link to this page or any pages linking to this page you must link directly to this page only here rather than put up your own page.

OJBTM

Online Journal of Bioinformatics ©

Volume 13(2):192-201, 2012

Drug target H1N2 (swine influenza) and H5N2 (avian influenza):ligand structure design

Arun Sivan¹, Stalin Antony²^*, Appadurai Daniel Reegan²

¹Regional medical Research Institute, ICMR, Port Blair and ²Division of bioinformatics, Entomology Research Institute, Loyola College, Chennai, India.

ABSTRACT

Sivan A, Antony S, Reegan AD., Drug target H1N2 (swine influenza) and H5N2 (avian influenza): ligand structure design, Online J Bioinform., 13(2):192-201, 2012. Molecular targets for H1N2 and H5N2 were identified and three dimensional structure of the target was developed using SWISS-MODEL automated protein structure homology-modeling server; modeled structure validated with RAMPAGE Server. The results of the Ramchandaran plot indicated the ranges: H1N2: 97% and H5N2:100%. Structural comparisons of the protein targets were performed using TOPMATCH tool to find out whether same ligand could be used for both Swine influenza (H1N2) and Avian influenza (H5N2). Docking analysis was carried out using suitable ligand molecules (Oseltamivir and Salicylic acid); both ligands were combined and generated a Denova ligand which showed more binding capacity.

Keywords: Avian influenza; Denova ligand; Docking analysis; Oseltamivir; Salicylic acid; Structural comparisons; structure validation; Swine influenza.

MAIN

FULL-TEXT (SUBSCRIPTION OR PURCHASE TITLE $25USD)